Activity Assay- ELISA The Binding Activity of SARS-CoV-2 Spike RBD Nanobody with SARS-CoV-2-S1-RBD Activity: Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2-S1-RBD (CSB-YP3324GMY1) at 2 microg/ml can bind SARS-CoV-2 Spike RBD Nanobody, the EC50 is 0.8674 ng/ml.
Activity Assay- ELISA The Binding Activity of SARS-CoV-2 Spike RBD Nanobody with SARS-CoV-2-S1-RBD Activity: Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2-S1-RBD (CSB-YP3324GMY1) at 2 microg/ml can bind SARS-CoV-2 Spike RBD Nanobody, the EC50 is 0.8674 ng/ml.
SARS-CoV-2 Spike RBD Nanobody
CSB-RA33245A2GMY
ApplicationsELISA, Neutralisation/Blocking, Other Application
Product group Antibodies
ReactivityVirus
TargetS
Overview
- SupplierCusabio
- Product NameSARS-CoV-2 Spike RBD Nanobody
- Delivery Days Customer20
- ApplicationsELISA, Neutralisation/Blocking, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDA1
- ConjugateUnconjugated
- Gene ID43740568
- Target nameS
- Target descriptionsurface glycoprotein
- Target synonymsGU280_gp02; spike glycoprotein; surface glycoprotein
- IsotypeIgG1
- Protein IDP0DTC2
- Protein NameSpike glycoprotein
- Scientific DescriptionRecombinant anti-SARS-CoV-2 spike VHH is expressed from 293 cells (HEK293) with a human IgG1 Fc tag on C-terminal.
- ReactivityVirus
- Storage Instruction-20°C or -80°C
- UNSPSC12352203